AGP Executive Report
Last update: 4 hours agoAutoimmune CAR-T Safety: Novartis and Bristol Myers Squibb paused multiple autoimmune CAR-T trials after safety concerns—Novartis reported fatal immune reactions in Rap-cel studies, while BMS halted Zola-cel enrollment after transient inflammatory events, with cancer trials still moving. Clinical Guidance Update: The American Academy of Neurology and American Headache Society released updated migraine prevention guidance for adults, replacing 2012 recommendations and outlining when to start and how to choose preventive meds. Gene Therapy Push: uniQure filed for FDA accelerated approval of its Huntington gene therapy ifezuntirgene inilparvovec (AMT-130), also submitting to the UK MHRA. Cardiac Imaging Standards: SCCT released updated CCTA recommendations aimed at more consistent reporting of plaque and stenosis, including expanded AI-related workflow guidance. Public Health & Equity: A major international JAMA Network Open review links intimate partner violence to higher child mortality, underscoring violence prevention as a health intervention. Workforce & Policy: Pennsylvania will audit home healthcare agencies after wage theft complaints surged, targeting overtime and pay violations. Health Tech & Research Capacity: Cleveland Clinic opened two major research buildings, adding 300,000 square feet for labs and core services.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
